Showing results (51-60 of 119) with videos related to
Sort By:
Pageof 12
Experimental Eye Research|January 1, 1987
The effect of levobunolol on aqueous humor dynamicsM E Yablonski, G D Novack, P J Burke, et al.Leukemia|May 1, 1990
Cure of acute myelocytic leukemia in adults: a realityR B Geller, R Saral, J E Karp, et al.The New England Journal of Medicine|July 3, 1986
Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemiaE R Fearon, P J Burke, C A Schiffer, et al.Blood|June 1, 1991
Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemiaB D Nelkin, D Przepiorka, P J Burke, et al.British Journal of Cancer|December 1, 1995
Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivoG T Rogers, P J Burke, S K Sharma, et al.Journal of Cutaneous Pathology|February 1, 1991
Endothelial expression of intercellular adhesion molecule (ICAM-1) is unaffected by marrow aplasia-inducing chemotherapyT D Horn, B J Kerker, J E Karp, et al.Cancer Treatment Reports|March 1, 1978
Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lungD S Ettinger, J E Karp, M D Abeloff, et al.Current Opinion in Immunology|October 6, 1999
Developments with targeted enzymes in cancer therapyK D Bagshawe, S K Sharma, P J Burke, et al.Cell Biophysics|January 1, 1994
Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenograftsS K Sharma, J A Boden, C J Springer, et al.Cancer Treatment Reports|November 1, 1981
Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc countsW P Vaughan, A W Kimball, J E Karp, et al.Pageof 12